1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. PARMAX PHARMA LTD.

Parmax Pharma Ltd.

BSE: 540359 | GSM

Download real time

48.94 4.24 (9.49%)

95.53% Gain from 52W Low

208 BSE Volume

BSE 11 Apr, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
16S
12W
0O
0T
18.3

Market Cap

Low in industry
-8.9

PE TTM

Negative PE TTM
-0.2

PEG TTM

PEG TTM is negative
-28.7

Price to Book

Negative Price to Book
0.3

Beta 1Year

Very Low volatility


Board Meetings - Parmax Pharma Ltd.

The latest board meeting for Parmax Pharma Ltd. took place on 14 Feb 2025, for the purpose of Quarterly Results

Share
Ex-date Purpose Notes
14 Feb 2025 Quarterly Results -
14 Nov 2024 Quarterly Results -
14 Aug 2024 Quarterly Results -
30 May 2024 Audited Results (Revised)
14 Feb 2024 Quarterly Results -
10 Nov 2023 Quarterly Results -
14 Aug 2023 Quarterly Results -
30 May 2023 Audited Results -
11 Feb 2023 Quarterly Results -
12 Nov 2022 Quarterly Results -
12 Aug 2022 Quarterly Results (Revised)
30 May 2022 Audited Results -
14 Feb 2022 Quarterly Results -
13 Nov 2021 Quarterly Results -
14 Aug 2021 Quarterly Results -
29 Jun 2021 Audited & Quarterly Results -
12 Feb 2021 Quarterly Results -
16 Jan 2021 Preferential Issue of shares Inter alia, 1. To approve the Preferential issue, Quantum and Determination of Issue Price of Securities.
12 Nov 2020 Quarterly Results -
15 Sep 2020 Quarterly Results -
31 Jul 2020 Audited Results -
12 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
09 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
17 Mar 2019 Others -
14 Feb 2019 Quarterly Results -
11 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results -
30 May 2018 Audited Results -
14 Feb 2018 Quarterly Results -
08 Dec 2017 Quarterly Results -
12 Aug 2017 Quarterly Results -
28 Nov 1997 Half Yearly Results -
04 Aug 1997 Accounts -